IntroductionFrom the moment you swallow a bite of food to the moment it exits your body, the gut is toiling to process this strange...

Earbuds equipped with biosensors can continuously measure the electrical activity of the brain and levels...

Richie Cunningham announced as Chief Executive Officer and member of Anebulo’s board of directors AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (“Anebulo”), a clinical-stage biopharmaceutical...

Introduction Just as people in different places seem to operate at different rhythms, so too do different species. They age at their own rates: Some,...

Mapping the uptake of glucose in the brain and body provides clinicians with information about...

A new nanowire structure that can be grown by a common bacterium could be used as an “electronic nose” to detect...

Interfacing neural tissue with electronics provides a way to investigate the complex electrical signalling characteristics...

IntroductionA mother gives her baby her all: love, hugs, kisses … and a sturdy army of bacteria. These simple cells, which journey from mother to...

Oral presentation at 64th American Society of Hematology Annual Meeting includes promising results from 81 patients with steroid-resistant, gastrointestinal acute Graft-versus-Host Disease (GI-aGvHD) treated...

DUBLIN–(BUSINESS WIRE)–The “RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global RNA interference (RNAi) drug delivery market reached a value of US$ 54.74 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 184.98 Billion by […]

The post Global RNA Interference Drug Delivery Market (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com appeared first on Fintech News.